Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates. (Q40292892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eran Bram

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ilan Ifergan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Assaf Shafran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Bluma Berman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gerrit Jansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

13 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

826-834

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16612649%20AND%20SRC:MED&resulttype=core&format=json

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

19 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00280-006-0230-9

Bryostatin-I: an antineoplastic treasure from the deep?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00280-006-0230-9